Printer Friendly

Articles from Biotech Business (April 1, 2004)

1-9 out of 9 article(s)
Title Author Type Words
BIOCRYST COMPLETES BCX-4208 PHASE I TRIAL FOR PSORIASIS. 625
CELLIANCE ADDS SERUM-FREE HYBRI-CYTE TO CELL CULTURE PORTFOLIO. 604
FDA SELECTS DISCOVERY LAB'S SURFAXIN PROGRAM FOR CMA PILOT 2. 786
NOBEX REPORTS ORAL INSULIN CLINICAL TRIAL PROMISING. 703
PROVENGE/AVASTIN IMPACT PSA DOUBLING TIME IN PROSTATE CANCER. 686
SCICLONE REPORTS ZADAXIN POSITIVE DATA FOR HEPATITIS PATIENTS. 930
TRIAGE STROKE PANEL PMA ACCEPTED FOR FDA REVIEW. 458
UNIGEN/NCI TO ISOLATE/IDENTIFY ANTI-SOLID TUMOR COMPOUNDS. 657
VERTEX LICENSES VX-944 TO AVALON FOR CANCER TREATMENT. 644

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters